SA19. N-Acetyl-Cysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis

Background: Biomarker-guided treatments are needed in psychiatry and previous data suggest redox dysregulation / oxidative stress may be a target in schizophrenia (1,2). A previous add-on trial with the antioxidant N-Acetyl-Cysteine (NAC) led to negative symptoms reductions in chronic patients (3)....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Schizophr Bull
Main Authors: Do, Kim, Seidman, Larry J., Fournier, Margot, Xin, Lijing, Cleusix, Martine, Baumann, Philipp S., Ferrari, Carina, Cousins, Ann, Alameda, Luis, Gholam-Rezaee, Mehdi, Golay, Philippe, Jenni, Raoul, Woo, T-U Wilson, Keshavan, Matcheri S., Eap, Chin B., Wojcik, Joanne, Cuenod, Michel, Buclin, Thierry, Gruetter, Rolf, Conus, Philippe
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475911/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbx023.018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados